Zimmer Biomet shares at $105 reveal value at 13 times adjusted earnings, as the company continues to grow despite a GLP-1 ...

Medical device company Zimmer Biomet (NYSE:ZBH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.3% year ...

We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at where Zimmer Biomet Holdings, Inc. (NYSE:ZBH) stands against other undervalued ...

At the end of January, Zimmer Biomet acquired Paragon 28, a medical device company focused exclusively on foot-and-ankle orthopedics. Through the $1.1 billion acquisition, Zimmer Biomet expects its ...

Zimmer Biomet to acquire Paragon 28 for $13/share, totaling $1.2B in enterprise value. Deal expected to close in H1 2025, with potential $1/share CVR based on 2026 sales milestones. Brand New ...

The firm spun out its dental and spine businesses in 2022. A Deep Dive into Zimmer Biomet Holdings's Financials Market Capitalization Analysis: Positioned below industry benchmarks, the company's ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report), ...

Please go ahead. Thank you, Operator, and good morning, everyone. Welcome to Zimmer Biomet Biomet's fourth quarter 2024 earnings conference call. Joining me on today's call are Iwan Tornos ...

In a report released today, Caitlin Cronin from Canaccord Genuity maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report), ...

Zimmer Biomet posted fourth-quarter revenue growth of 5% in constant currency, which is generally consistent with the preceding quarters in 2024. Why it matters: As Zimmer Biomet has pursued a ...

On Thursday, Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported fourth-quarter adjusted EPS of $2.31, up from $2.20 a year ago, beating the Street estimates of $2.30. The orthopedic giant reported ...

Zimmer Biomet Holdings ZBH underwent analysis by ... The firm spun out its dental and spine businesses in 2022. Market Capitalization Analysis: Positioned below industry benchmarks, the company's ...